East Asian Gynecologic Oncology Trial Group
Better treatment for East Asian women
through international clinical trials
East Asian Gynecologic Oncology Trial Group (EAGOT) is an international research organization focused on treatment for gynecological cancer in East Asian women.
The purpose of EAGOT is to coordinate and conduct international clinical trials in order to provide the best treatment for East Asian women who are affected by gynecological cancer. EAGOT is formed by national clinical trial groups in East Asia — Japanese Gynecologic Oncology Group (JGOG), Korean Gynecologic Oncology Group (KGOG), Chinese Anti-Cancer Association Integrated Gynecological Oncology (CHISGO), and Taiwanese Gynecologic Oncology Group (TGOG).
EAGOT focuses on academic clinical trials, translational research, rare disease research, and clinical trials revolving around multinational studies in East Asia.
Since2021
Our Mission
To coordinate and conduct international clinical trials in an effort to provide best treatments to East-Asian women with gynecologic cancer
What We Focus On
-
01
Academic Clinical Trials
Investigator-initiated multinational trials designed and run together by the member groups.
-
02
Translational Research
Research that connects laboratory findings with treatment for patients in East Asia.
-
03
Rare Disease Research
Collaboration across countries to study gynecologic cancers that are too rare for one nation alone.
-
04
Multinational Studies
A regional platform for industry- and government-sponsored studies conducted in East Asia.
Member Groups
- JGOG Japanese Gynecologic Oncology Group Japan
- KGOG Korean Gynecologic Oncology Group Korea
- CHISGO Chinese Anti-Cancer Association Integrated Gynecological Oncology China
- TGOG Taiwanese Gynecologic Oncology Group Taiwan